Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Epigenetic dysregulation, which leads to the alteration of gene expression in the brain, is suggested as one of the key pathophysiological bases of ageing and neurodegeneration. Here we found that, in the late-stage familial Alzheimer's disease (FAD) mouse model, repressive histone H3 dimethylation at lysine 9 (H3K9me2) and euchromatic histone methyltransferases EHMT1 and EHMT2 were significantly elevated in the prefrontal cortex, a key cognitive region affected in Alzheimer's disease. Elevated levels of H3K9me2 were also detected in the prefrontal cortex region of post-mortem tissues from human patients with Alzheimer's disease. Concomitantly, H3K9me2 at glutamate receptors was increased in prefrontal cortex of aged FAD mice, which was linked to the diminished transcription, expression and function of AMPA and NMDA receptors. Treatment of FAD mice with specific EHMT1/2 inhibitors reversed histone hyper-methylation and led to the recovery of glutamate receptor expression and excitatory synaptic function in prefrontal cortex and hippocampus. Chromatin immunoprecipitation-sequencing (ChIP-seq) data indicated that FAD mice exhibited genome-wide increase of H3K9me2 enrichment at genes involved in neuronal signalling (including glutamate receptors), which was reversed by EHMT1/2 inhibition. Moreover, the impaired recognition memory, working memory, and spatial memory in aged FAD mice were rescued by the treatment with EHMT1/2 inhibitors. These results suggest that disrupted epigenetic regulation of glutamate receptor transcription underlies the synaptic and cognitive deficits in Alzheimer's disease, and targeting histone methylation enzymes may represent a novel therapeutic strategy for this prevalent neurodegenerative disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The diminished transcription of NMDA and AMPA receptors in late-stage AD mouse models has been linked to the EHMT1/2-mediated repressive histone methylation at their promoters 256.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [256]
In the citing paper
“Treatment of AD models with specific EHMT1/2 inhibitors reverses the increased H3K9me2 enrichment at genes involved in neuronal signaling (e.g. Grin2b encoding NR2B subunit and Gria2 encoding GluR2 subunit), restores glutamate receptor expression and excitatory synaptic function in PFC, and rescues the impaired recognition memory, working memory, and spatial memory 256 (Fig. 5).”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [256]
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“histone modifying enzymes, which is associated with gene activation or repression (Barski et al., 2007; Heintzman et al., 2007).”
BackgroundSelf-citationThe Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“Genotyping were performed by PCR according to the manufacturer’s protocol (Oakley et al., 2006; Yoshiyama et al., 2007).”
BackgroundMethodHeintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 1×
“histone modifying enzymes, which is associated with gene activation or repression (Barski et al., 2007; Heintzman et al., 2007).”
BackgroundSelf-citationCellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · cited 1×
“Excessive amyloid-b depresses excitatory synaptic transmission (Kamenetz et al., 2003), resulting in chronic activity deprivation.”
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Self-citation
Research works printed but not linked: 1
- Sperfeld, 1999, FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation, Ann Neurol, 46, 708, 10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k · doi:10.1002/1531-8249(199911)46:5<708::aid-ana5>3.0.co;2-k
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Yan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
Self-citationThe role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 297
Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
Migliore, L., & Coppedè, F. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00714-w · Cited by 217
Epigenetic Mechanisms in Memory and Cognitive Decline Associated with Aging and Alzheimer’s Disease
Maity, S., Farrell, K., Navabpour, S., Narayanan, S. N., & Jarome, T. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212280 · Cited by 135
Calderón‐Garcidueñas, L., Herrera-Soto, A., Jury, N., Maher, B. A., González-Maciel, A., Reynoso-Robles, R., Ruiz-Rudolph, P., van Zundert, B., & Varela‐Nallar, L. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109226 · Cited by 122
Histone Modifications in Alzheimer’s Disease
Santana, D. A., Smith, M. D. A. C., & Chen, E. (2023) · Genes · doi:10.3390/genes14020347 · Cited by 118
Cao, Q., Wang, W., Williams, J. B., Yang, F., Wang, Z.-J., & Yan, Z. (2020) · Science Advances · doi:10.1126/sciadv.abc8096 · Cited by 108
Self-citationHistone Methylation Regulation in Neurodegenerative Disorders
Basavarajappa, B. S., & Subbanna, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094654 · Cited by 105
Li, H., Tan, Y., Cheng, X. M., Zhang, Z., Huang, J., Hui, S., Zhu, L., Liu, Y., Zhao, D. S., Liu, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.990307 · Cited by 105
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer’s disease
Lin, Y., Lin, A., Cai, L., Huang, W., Yan, S., Wei, Y., Ruan, X., Fang, W., Dai, X., Cheng, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00625-4 · Cited by 102
Self-citationGriñán-Ferré, C., Marsal-García, L., Bellver-Sanchis, A., Kondengaden, S. M., Turga, R. C., Vázquez, S., & Pallàs, M. (2019) · Aging · doi:10.18632/aging.102558 · Cited by 81
Rothammer, N., Woo, M. S., Bauer, S., Binkle-Ladisch, L., Di Liberto, G., Egervari, K., Wagner, I., Haferkamp, U., Pless, O., Merkler, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm5500 · Cited by 69
Eight novel susceptibility loci and putative causal variants in atopic dermatitis
Tanaka, N., Koido, M., Suzuki, A., Otomo, N., Suetsugu, H., Kochi, Y., Tomizuka, K., Momozawa, Y., Kamatani, Y., Ikegawa, S., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.04.019 · Cited by 74
Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 73
Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions
Jin, M., & Cai, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00969-9 · Cited by 71
Role of histone modifications in neurogenesis and neurodegenerative disease development
Zhao, A., Xu, W., Han, R., Wei, J., Qi, Y., Wang, M., Li, H., Li, M., & Chi, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102324 · Cited by 71
Self-citationPrasanth, M. I., Sivamaruthi, B. S., Cheong, C. S. Y., Verma, K., Tencomnao, T., Brimson, J. M., & Prasansuklab, A. (2024) · Antioxidants · doi:10.3390/antiox13050606 · Cited by 71
Discovery of the First-in-Class G9a/GLP Covalent Inhibitors
Park, K., Xiong, Y., Yim, H., Velez, J., Babault, N., Kumar, P., Liu, J., & Jin, J. J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00652 · Cited by 62
Omics-based biomarkers discovery for Alzheimer's disease
Aerqin, Q., Wang, Z.-T., Wu, K., He, X., Dong, Q., & Yu, J. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04614-6 · Cited by 59
Self-citationRole of primary aging hallmarks in Alzheimer´s disease
Zhao, J., & Huai, J. (2023) · Theranostics · doi:10.7150/thno.79535 · Cited by 51
Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Jiang, D., Li, T., Guo, C., Tang, T.-S., & Liu, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00953-4 · Cited by 54
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xiao, X., Liu, X., & Jiao, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.538301 · Cited by 55
Li, Y., Zhu, K., Li, N., Wang, X., Xiao, X., Li, L., Li, L., He, Y., Zhang, J., Wo, J., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00859-8 · Cited by 53
Self-citationSirtuins and cognition: implications for learning and memory in neurological disorders
Fagerli, E. A., Escobar, I., Ferrier, F. J., Jackson, C. W., Lao, E. J. P., & Pérez‐Pinzón, M. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.908689 · Cited by 51
Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Pereira, M. S., Cruz, M. T., Fortuna, A. C., & Bicker, J. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104052 · Cited by 49
One-carbon epigenetics and redox biology of neurodegeneration
Coppedè, F. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.002 · Cited by 46
The plasma peptides of Alzheimer’s disease
Florentinus-Mefailoski, A., Bowden, P., Scheltens, P., Killestein, J., Teunissen, C. E., & Marshall, J. G. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09320-2 · Cited by 45
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Jin, S., Lü, W., Zhang, J., Zhang, L., Tao, F., Zhang, Y., Hu, X., & Liu, Q. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.005 · Cited by 44
Li, Y., Sun, M., Wang, X., Cao, X., Li, N., Pei, D., & Li, A. (2022) · International Journal of Oral Science · doi:10.1038/s41368-022-00191-3 · Cited by 44
Self-citationEpigenetics of the Synapse in Neurodegeneration
Xylaki, M., Atzler, B., & Outeiro, T. F. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0995-y · Cited by 40
Shu, S., Xu, S., Ye, L., Liu, Y., Cao, X., Jia, J., Bian, H.-J., Liu, Y., Zhu, X., & Xu, Y. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01435-w · Cited by 40
Jury, N., Abarzua, S., Diaz, I., Guerra, M. V., Ampuero, E., Cubillos, P., Martinez, P., Herrera-Soto, A., Arredondo, C., Rojas, F., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0816-9 · Cited by 35
Olawade, D. B., Rashad, I., Egbon, E., Teke, J., Ovsepian, S. V., & Boussios, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104929 · Cited by 37
Williams, J. B., Cao, Q., Wang, W., Lee, Y., Qin, L., Zhong, P., Ren, Y., Ma, K., & Yan, Z. (2023) · Nature Communications · doi:10.1038/s41467-022-35749-6 · Cited by 37
Self-citationGenetic Variants and Oxidative Stress in Alzheimer’s Disease
Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 36
Comparative Effects of Brominated Flame Retardants BDE-209, TBBPA, and HBCD on Neurotoxicity in Mice
Wang, J., & Dai, G.-D. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00126 · Cited by 36
Patel, P. J., Ren, Y., & Yan, Z. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106192 · Cited by 36
Self-citationAlzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets
Paniri, A., Hosseini, M. M., & Akhavan‐Niaki, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03626-y · Cited by 36
Epigenetic Neuropharmacology: Drugs Affecting the Epigenome in the Brain
Tóth, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-022920 · Cited by 35
Nuclear dynamics and stress responses in Alzheimer’s disease
Iatrou, A., Clark, E. M., & Wang, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00489-6 · Cited by 34
Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model
Wang, W., Cao, Q., Tan, T., Yang, F., Williams, J. B., & Yan, Z. (2021) · Aging Cell · doi:10.1111/acel.13456 · Cited by 33
Self-citationZhao, M., Zhu, Z., Li, H., Wang, W., Cheng, S., Qin, X., Wu, H., Liu, D., & Pan, F. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.101 · Cited by 33
Self-citationAging‐related histone modification changes in brain function
Ding, Y., Liu, C., & Zhang, Y. (2023) · Ibrain · doi:10.1002/ibra.12106 · Cited by 33
Epigenetic regulation in Alzheimer’s disease: is it a potential therapeutic target?
Coppedè, F. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1916469 · Cited by 31
Neuroepigenetics of ageing and neurodegeneration-associated dementia: An updated review
Mir, F. A., Amanullah, A., Jain, B. P., Hyderi, Z., & Gautam, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102067 · Cited by 31
Muneer, A., Wang, L., Xie, L., Zhang, F., Wu, B., Liu, M., Lenarcic, E. M., Feng, E. H., Song, J., Xiong, Y., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.012 · Cited by 31
Self-citationCirculating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
Adams, C. D. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s239350 · Cited by 30
A convergent mechanism of high risk factors ADNP and POGZ in neurodevelopmental disorders
Conrow‐Graham, M., Williams, J. B., Martin, J. A., Zhong, P., Cao, Q., Rein, B. A., & Yan, Z. (2022) · Brain · doi:10.1093/brain/awac152 · Cited by 29
Self-citationThe role of epigenetic modification in postoperative cognitive dysfunction
Wu, W.-F., Lin, J.-T., Qiu, Y.-K., Dong, W., Wan, J., Li, S., Zheng, H., & Wu, Y.-Q. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101983 · Cited by 29
Increase in hippocampal histone H3K9me3 is negatively correlated with memory in old male mice
Kushwaha, A., & Thakur, M. K. (2019) · Biogerontology · doi:10.1007/s10522-019-09850-1 · Cited by 30
Epigenetic enzymes: A role in aging and prospects for pharmacological targeting
PASYUKOVA, E. G., Symonenko, A. V., Rybina, O. Y., & Vaiserman, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101312 · Cited by 29
Vasilopoulou, F., Bellver‐Sanchís, A., Companys‐Alemany, J., Jarné‐Ferrer, J., Irisarri, A., Palomera‐Ávalos, V., González-Castillo, C., Ortuño‐Sahagún, D., Sanfeliu, C., Pallàs, M., et al. (2022) · Cells · doi:10.3390/cells11162603 · Cited by 27
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease
Bellver‐Sanchís, A., Geng, Q., Navarro, G., Ávila-López, P. A., Companys‐Alemany, J., Marsal-García, L., Larramona‐Arcas, R., Miró, L., Pérez‐Bosque, A., Ortuño‐Sahagún, D., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.0424-2 · Cited by 27
Alzheimer’s Disease: the Potential of Epigenetic Treatments and Current Clinical Candidates
Coneys, R., & Wood, I. C. (2020) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0034 · Cited by 27
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111658 · Cited by 26
Biological and therapeutic role of LSD1 in Alzheimer’s diseases
Li, Y., Zhao, Y., Li, X., Zhai, L., Zheng, H., Yan, Y., Fu, Q., Ma, J., Fu, H., Zhang, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1020556 · Cited by 26
Qin, Y., Yang, P. C., He, W., Li, D., Zeng, L., Li, J., Zhou, T., Peng, J., Cao, L., & Huang, W. G. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01650-w · Cited by 26
Insights into the Role of Histone Methylation in Brain Aging and Potential Therapeutic Interventions
Vitorakis, N., & Piperi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417339 · Cited by 25
Discovery of the First-in-Class G9a/GLP PROTAC Degrader
Velez, J., Han, Y., Yim, H., Yang, P., Deng, Z., Park, K., Kabir, M., Kanıskan, H. Ü., Xiong, Y., & Jin, J. J. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02394 · Cited by 25
van Zundert, B., & Montecino, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012081 · Cited by 21
Fisher, R. M. A., & Torrente, M. P. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1456052 · Cited by 20
Yue, S., Wang, Y., & Wang, Z. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109204 · Cited by 20
Self-citationAMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets
Ning, L., Shen, R., Xie, B., Jiang, Y., Geng, X., & Dong, W. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae093 · Cited by 20
Epigenetics in Neurodegenerative Diseases
van Zundert, B., & Montecino, M. A. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_3 · Cited by 20
Xie, L., Sheehy, R. N., Muneer, A., Xiong, Y., Wrobel, J. A., Zhang, F., Park, K., Velez, J., Liu, J., Luo, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59128-z · Cited by 20
Self-citationPolygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
Liu, H., Dehestani, M., Blauwendraat, C., Makarious, M. B., Leonard, H. L., Kim, J. J., Schulte, C., Noyce, A. J., Jacobs, B. M., Foote, I. F., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26416 · Cited by 20
Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression
Duggan, M. R., Gómez, G., Joynes, C. M., Bilgel, M., Chen, J., Fattorelli, N., Hohman, T. J., Mancuso, R., Cordon, J., Castellano, T., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.002 · Cited by 19
The interplay between histone modifications and nuclear lamina in genome regulation
Sun, C., Zhao, Y., Guo, L., Qiu, J., & Peng, Q. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.10.005 · Cited by 18
Zhou, B., Li, J., Wu, A., Wang, X., Cheng, L., Yang, G., Gao, D., & Zhu, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587986 · Cited by 18
Self-citationLiu, P., Dai, S., Mi, T., Tang, G.-B., Wang, Z., Wang, H., Du, H., Tang, Y., Teng, Z., & Liu, C. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202215795 · Cited by 18
Self-citationLin, L., Liu, A., Li, H., Feng, J., & Yan, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190190 · Cited by 18
Self-citationLi, J. Z., Ramalingam, N., & Li, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01827 · Cited by 17
Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse model
Zhang, Z., Wang, R., Zhou, H., Wu, D., Cao, Y., Zhang, C., Sun, H., Mu, C., Hao, Z., Ren, H., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05176-5 · Cited by 17
A unified model of dementias and age‐related neurodegeneration
Fossel, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12012 · Cited by 17
Han, J. L. T., Pang, K. K. L., Ang, S. R. X., Sharma, M., & Sajikumar, S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00247-0 · Cited by 17
Bellver‐Sanchís, A., Choudhary, B. S., Companys‐Alemany, J., Sukanya, S., Ávila-López, P. A., Martínez, A. L., Floriani, J. M. B., Malik, R., Pallàs, M., Pérez, B., et al. (2022) · ChemMedChem · doi:10.1002/cmdc.202200002 · Cited by 17
Wang, W., Tan, T., Cao, Q., Zhang, F., Rein, B. A., Duan, W., & Yan, Z. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac048 · Cited by 17
Self-citationGao, J., Liu, W., Liu, J., Hao, N., Pei, J., & Zhang, L. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04045-0 · Cited by 16
Rapanelli, M., Wang, W., Hurley, E. L., Feltri, M. L., Pittenger, C., Frick, L. R., & Yan, Z. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02306-8 · Cited by 16
Self-citationReed, L., Abraham, J., Patel, S., & Dhar, S. S. (2024) · Biology · doi:10.3390/biology13121008 · Cited by 15
Wang, S. E., Xiong, Y., Jang, M., Park, K., Donahue, M., Velez, J., Jin, J., & Jiang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.034 · Cited by 14
Histone Methylation, Energy Metabolism, and Alzheimer's Disease
Fu, J., & An, L. (2024) · Aging and Disease · doi:10.14336/ad.2024.0899 · Cited by 14
Bellver‐Sanchís, A., Ribalta‐Vilella, M., Irisarri, A., Gehlot, P., Choudhary, B. S., Jana, A., Vyas, V. K., Banerjee, D. R., Pallàs, M., Guerrero, A., et al. (2025) · Medicinal Research Reviews · doi:10.1002/med.22096 · Cited by 14
Wan, L., Zhong, P., Li, P. S., Ren, Y., Wang, W., Yu, M., Feng, H. Y., & Yan, Z. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106826 · Cited by 14
Self-citationExploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease
Liu, H., Xie, Y., Wang, X., Abboud, M. I., Ma, C., Ge, W., & Schofield, C. J. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12733 · Cited by 14
Self-citationCao, Q., Kumar, M., Frazier, A., Williams, J. B., Zhao, S., & Yan, Z. (2023) · Aging · doi:10.18632/aging.205057 · Cited by 13
Self-citationAlves, V. C., Figueiro‐Silva, J., Ferrer, I., & Carro, E. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04845-1 · Cited by 13
Histone modifications: Key players in Alzheimer's disease
Li, K., Qiu, X., Yang, Q., & Wang, Z. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112102 · Cited by 12
Self-citationThe epigenetic reader PHF21B modulates murine social memory and synaptic plasticity–related genes
Chin, E., Ma, Q., Ruan, H., Chin, C., Somasundaram, A., Zhang, C., Liu, C., Lewis, M. D., White, M., Smith, T. L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.158081 · Cited by 12
Bellver‐Sanchís, A., Ávila-López, P. A., Tic, I., Valle‐García, D., Ribalta‐Vilella, M., Labrador, L., Banerjee, D. R., Guerrero, A., Casadesús, G., Poulard, C., et al. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.393102 · Cited by 11
Carballo, L. G. H., Li, P., Senek, R., & Yan, Z. (2024) · The Journal of Physiology · doi:10.1113/jp285875 · Cited by 11
Self-citationLopes, C. R., Silva, J. S., Santos, J., Rodrigues, M. S., Madeira, D., Oliveira, A., Moreira-de-Sá, A., Lourenço, V. S., Gonçalves, F. Q., Silva, H. B. L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086968 · Cited by 11
Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent
Jana, A., Bellver‐Sanchís, A., Griñán‐Ferré, C., & Banerjee, D. R. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00344 · Cited by 10
Hajar, M., Werner, T., Gajić, M., Stark, H., & Sadek, B. S. (2025) · Medicinal Research Reviews · doi:10.1002/med.22119 · Cited by 9
An epigenetic mechanism of social isolation stress in adolescent female mice
Li, P., & Yan, Z. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100601 · Cited by 9
Self-citationThe Role of Dynamic Histone Modifications in Learning Behavior
Fischer, A. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_108 · Cited by 9
Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
Cahill, M. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2711318 · Cited by 9
Kim, Y. A., Mellén, M., Kızıl, Ç., & Santa‐María, I. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16280 · Cited by 9
Chai, G., Gong, J., Mao, Y.-M., Wu, J.-J., Bi, S.-G., Wang, F., Zhang, Y., Shen, M.-T., Lei, Z.-Y., Nie, Y., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03995-y · Cited by 8
Metadata
- Authors
- Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., Cheng, J., Chen, G.-J., Wang, X., & Yan, Z.
- Affiliations
- Capital Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
- University at Buffalo, State University of New York (US)
- VA Western New York Healthcare System (US)
- Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, P.R.China
- Corresponding author
- Zheng, Yan
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-01-22
- Volume
- 142
- Issue
- 3
- Pages
- 787-807
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6391616
- OpenAlex
- W2914500235
- Cited by
- 168
- References
- 73
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 38 · 2023: 25 · 2022: 29 · 2021: 18 · 2020: 13 · 2019: 7
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- VA Merit (I01BX001633)
- National Institutes of Health (R01-AG056060)
- National Key Research and Development Program of China (2016YFC1306300, 81571038, 81771145)
- NSFC (81171197, 81220108010)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, EHMT1, G9a, H3K9me2, histone methylation, epigenetic dysregulation, glutamate receptors, AMPA receptors, NMDA receptor, synaptic function, prefrontal cortex, hippocampus, memory impairment, gene transcription
- MeSH terms
- Alzheimer Disease, Animals, Chromosome Deletion, Cognition, Cognition Disorders, Disease Models, Animal, Hippocampus, Histocompatibility Antigens, Histones, Humans, Lysine, Memory Disorders, Methylation, Mice, Transgenic, Histone-Lysine N-Methyltransferase, Synapses, Prefrontal Cortex, DNA Methylation, Epigenesis, Genetic, Mice, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.